Biomedical Ethics and Regulation
Moving in EMBO Reports.
- Moved, week to 23 Oct 2026
- 1
- Papers in 60 days
- 9
Rebuilt
Moved this week
Latest in Biomedical Ethics and Regulation
Newest first · last 60 days
Genomic and transcriptomic qualification of patient-derived dopaminergic neuron precursors was successfully demonstrated across multiple donors for an autologous iPSC-based therapy for Parkinson's disease.
- Open access
Human pluripotent stem cell-derived dopaminergic progenitors are safe for transplantation in Parkinson's disease patients, with no serious adverse events observed over 12 months.
- Open access
Induced pluripotent stem cell technology has advanced from discovery to a promising clinical platform with early therapeutic trials and approvals.
Regulatory fragmentation creates significant challenges for SynBioxAI research, with ambiguities causing multiplicative friction across sixteen nations.
- Open access
Browse JClub
Journals this month
- bioRxiv6131
- medRxiv1703
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3
